Neurovax

From Wikipedia, the free encyclopedia

Neurovax is a vaccine designed to treat patients with Multiple Sclerosis (M.S.). Developed by Orchestra Therapeutics, it is currently in phase II clinical trials. Neurovax is designed to stimulate FOXP3+ regulatory T-cells that can then suppress the autoreactive T-cells in some patients.

[1]

This medical article is a stub. You can help Wikipedia by expanding it.